CARL
Carlsmed, Inc.
14.80$
-4.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.3% | +19.6% | +8.4% | +42.8% | +8.3% | +18.6% | +8.2% | +16.0% | +6.3% | +17.5% | – | |
| – | +17.0% | +6.8% | +18.0% | +33.0% | +7.1% | +25.9% | -2.1% | +13.0% | +3.8% | +19.2% | – | |
| – | +17.4% | +24.5% | +5.2% | +46.4% | +8.7% | +16.1% | +11.9% | +16.9% | +7.0% | +17.0% | – | |
| – | – | +22.8% | +0.9% | -25.3% | +4.5% | +32.1% | +6.9% | +18.4% | -1.6% | +16.6% | – | |
| – | – | -6.1% | -4.6% | +21.3% | +49.0% | -3.6% | +46.8% | -1.1% | +28.3% | +22.4% | – | |
| – | +5.1% | +21.0% | -127.4% | – | -73.6% | +15.1% | +23.4% | +10.4% | +3.7% | +17.9% | – | |
| – | – | – | – | -659.9% | – | – | – | – | – | – | – | |
| – | – | +50.5% | +23.7% | -6.0% | -5.6% | +1.7% | +4.7% | -13.2% | -5.8% | +0.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.